Press Release: BioSkryb : BioSkryb Genomics Unveils New Research Findings Related to Breast Cancer Tumor Evolution
DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb will share new research related to single-cell analysis of breast cancer biopsies and the expansion of ResolveDNA® at AACR 2023
Read full article »
BioSkryb is a North Carolina-based company that provides services such as single-cell molecular discovery and analysis for the biotech industry.
Read more